India's Emergence as a Global Vaccine Manufacturer ft Adar Poonawalla

Adar Poonawalla, CEO, Serum Institute of India, shares his experiences in manufacturing the COVID vaccines for India and the world. Adar is in conversation with Rajan Navani, Chairman, CII’s India@75 Council and Vice Chairman & Managing Director, Jetline Group of Companies. As India recently scripted history by reaching past the 1 billion vaccination milestone, how will it affect the behaviour of the Omicron variant in India? Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Dec 24, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

India's Emergence as a Global Vaccine Manufacturer ft Adar Poonawalla

0:00 27:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CII Podcasts?

This episode is 27 minutes long.

When was this CII Podcasts episode published?

This episode was published on December 24, 2021.

Can I download this CII Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!